Last $136.51 USD
Change Today 0.00 / 0.00%
Volume 0.0
SIAL On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

sigma-aldrich (SIAL) Snapshot

Open
$136.22
Previous Close
$136.50
Day High
$136.74
Day Low
$136.21
52 Week High
09/22/14 - $138.01
52 Week Low
12/23/13 - $90.20
Market Cap
16.3B
Average Volume 10 Days
678.4K
EPS TTM
$4.22
Shares Outstanding
119.1M
EX-Date
11/26/14
P/E TM
32.4x
Dividend
$0.92
Dividend Yield
0.67%
Current Stock Chart for SIGMA-ALDRICH (SIAL)

sigma-aldrich (SIAL) Related Businessweek News

No Related Businessweek News Found

sigma-aldrich (SIAL) Details

Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment worldwide. Its chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. The company sells its products to commercial laboratories, pharmaceutical companies, industrial companies, universities, diagnostics companies, biotechnology companies, electronics companies, hospitals, governmental institutions, and non-profit organizations. Sigma-Aldrich Corporation was founded in 1951 and is based in St. Louis, Missouri.

9,000 Employees
Last Reported Date: 10/23/14
Founded in 1951

sigma-aldrich (SIAL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $876.9K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $465.4K
Executive Vice President and President of App...
Total Annual Compensation: $437.7K
Executive Vice President and President of SAF...
Total Annual Compensation: $386.5K
Executive Vice President and President of Res...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2013.

sigma-aldrich (SIAL) Key Developments

Sigma-Aldrich Corporation(NasdaqGS:SIAL) dropped from S&P 500 Value Index

Sigma-Aldrich Corporation(NasdaqGS:SIAL) dropped from S&P 500 Value Index

Indi Molecular and Sigma-Aldrich Establishes Collaboration to Explore Use of PCC Technology in Biological Tools

Indi Molecular announced that it has entered into a co-development agreement with Sigma-Aldrich to explore the use of Indi Molecular's PCC technology with Sigma-Aldrich's line of biological tools. PCC (protein catalyzed capture) agent technology is a breakthrough process that produces synthetic peptide molecules capable of binding interactions that are equivalent or superior to molecular antibodies. Current systems employ antibody-based biological tools that are used to capture proteins and enable highly sensitive detection. The joint research and development project will explore the use of PCCs to specifically interact with proteins. PCC agents are molecules designed to exhibit the attractive features of monoclonal antibodies, plus additional features that can enable applications in the commercial spaces of in vivo imaging, therapeutics, in vitro diagnostics and biological tools. PCCs have several advantages over antibodies, including lower cost, faster development and greater specificity.

Sigma-Aldrich Corporation's Cerilliant Introduces New CRMs for Cannabis Testing Applications

Sigma-Aldrich Corporation has announced that the Cerilliant brand within its applied diagnostics and testing business segment has introduced new solution-based certified reference materials, or CRMs, of seven Cannabis biomarkers for Cannabis testing applications. The seven Cannabis biomarkers are cannabidivarin, cannabigerol, cannabigerolic acid, cannabichromene, cannabidiolic acid, delta9-tetrahydrocannabinolic acid A, and tetrahydrocannabivarin. These cannabinoid CRMs are suitable for use in Cannabis testing applications by GC, GC/MS, HPLC, or LC-MS/MS, including potency testing, cannabinoid and impurity profiling, pharmaceutical research, or forensic analysis. Cerilliant provides these and other certified solution standards of cannabinoids in a US DEA and Health Canada exempt solution format, allowing laboratories to place orders without additional regulatory paperwork.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIAL:US $136.51 USD 0.00

SIAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,238 INR +38.45
International Flavors & Fragrances Inc $102.49 USD 0.00
Symrise AG €50.31 EUR +0.79
UCB SA €65.92 EUR +0.13
Waters Corp $115.09 USD 0.00
View Industry Companies
 

Industry Analysis

SIAL

Industry Average

Valuation SIAL Industry Range
Price/Earnings 33.0x
Price/Sales 5.9x
Price/Book 5.2x
Price/Cash Flow 32.6x
TEV/Sales 5.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA-ALDRICH, please visit www.sigmaaldrich.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.